World Orphan Drugs Rare Disease Congress

GCT is taking part in World Orphan Drugs Rare Disease Congress.

The World Orphan Drug Congress USA is a digital media and events platform for the rare disease community.

Nataliya Katsnelson, Senior Director of Business Development, is representing GCT in panel discussions, round tables, and keynote presentations.

Reach out to Nataliya to find more about placing clinical trials in the current situation.

Updated: March 3, 2021

Permanent link: https://2022.gctrials.com/posts/world-orphan-drugs-rare-disease-congress/

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2021 Global Clinical Trials, LLC

All rights reserved.